Royalty Pharma Plc
$34.84
(as of Jun 13, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Royalty Pharma Plc
Stock Price
$34.84
Ticker Symbol
RPRX
Exchange
NASDAQ
Industry Information for Royalty Pharma Plc
Sector
Healthcare
Industry
Biotechnology
Company Description for Royalty Pharma Plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Fundamentals for Royalty Pharma Plc
Market Capitalization
$18,889,220,096
EBITDA
$1,497,820,032
Dividends per Share
$0.84
P/E Ratio
17.22
Forward P/E Ratio
10.58
Earnings per Share
$1.91
Earnings per Share Estimate Next Year
Profit Margin
37.95%
Shares Outstanding
433,444,992
Percent Owned by Insiders
9.87%
Percent Owned by Institutions
76.95%
52-Week High
52-Week Low
Technical Indicators for Royalty Pharma Plc
Analyst Ratings for Royalty Pharma Plc
Strong Buy
5
Buy
2
Hold
1
Sell
0
Strong Sell
0
News About Royalty Pharma Plc
Jun 9, 2025, 9:54 AM EST
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) met the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $568.2 million. See more.
Jun 6, 2025, 12:32 AM EST
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. See more.
Jun 4, 2025, 4:15 PM EST
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 2:00 p.m. See more.
Jun 4, 2025, 4:15 PM EST
Royalty Pharma plc
See more.